Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.
about
The Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and PlacentationBiochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseModulation of cellular redox homeostasis by the endocannabinoid systemEndocannabinoids as Guardians of MetastasisExpression and Function of the Endocannabinoid System in the Retina and the Visual BrainZebrafish as a Model to Study the Role of Peroxisome Proliferating-Activated Receptors in Adipogenesis and ObesityVascular targets for cannabinoids: animal and human studiesBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemIs the cardiovascular system a therapeutic target for cannabidiol?Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future AntidepressantsTime-dependent vascular effects of Endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARγ)Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionPhytocannabinoids beyond the Cannabis plant - do they exist?Omega-3 Fatty Acids and PPARgamma in CancerCannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvementBiochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibitionType 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoidsBlockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptorsGanaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorderRegulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation.Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsSubstrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activationFrom Fertilisation to Implantation in Mammalian Pregnancy-Modulation of Early Human Reproduction by the Endocannabinoid System.The endocannabinoid system: 'NO' longer anonymous in the control of nitrergic signalling?Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityA natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).Endocannabinoid metabolism in neurodegenerative diseasesPlasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in womenMass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism.Endocannabinoids in synaptic plasticity and neuroprotection.Animal models of cannabinoid reward.The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184A common haplotype in NAPEPLD is associated with severe obesity in a Norwegian population-based cohort (the HUNT study).Psychopharmacology of the endocannabinoids: far beyond anandamide.Adolescent exposure to cannabis as a risk factor for psychiatric disorders.The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.
P2860
Q21284856-B6DDC69F-25A0-46AC-B1B1-672471C96D6DQ24620186-BEB82E42-A06D-4E29-B383-CB5AF414F8CDQ26744211-156196D6-DBC5-448D-B4F1-ECF64DF8DB33Q26766163-C530ECAE-9958-470B-AD3B-3BBDC605A9CCQ26769951-96FA26AD-31AF-4D64-9489-02761AFB7979Q26772316-CB64703C-0D5D-4C93-9AEC-CDB1A49F33C9Q26862515-BFD2287E-8599-4013-86BF-BDC00780EF8EQ26865295-9D26E2D7-745B-440E-A11D-71BE74D352E4Q26865370-5F441975-BCB8-43B0-8448-4A797DB8262FQ28082891-32D354E9-6D0E-4D18-B030-E6BA2B310E6AQ28243980-6D5323D2-08AF-4499-8C47-A2F436D10F56Q28283718-37541F83-A9E2-4012-A184-3DCC9F80060AQ28286497-20AC201F-B40C-418B-973A-8A4D1F51C3E9Q28292907-A96E2154-F472-4BFE-9BDE-7D224A50F6BBQ28394506-C98ED05C-DC02-4568-A260-918789211DB2Q28483214-7E333B5A-42A0-4B93-A4CB-435026B8B2D9Q28485117-0D49AF54-9D9D-4EA5-B2B5-D71133393D95Q28582567-54BEC1C5-3E17-4461-8902-3CBD6B002FA8Q30428666-0CDC3752-C729-462F-89A2-BC96BF6B1DFCQ30470076-E5998A79-F441-4B12-BBB0-8F7589907043Q30472672-C7B215DC-18E4-4A56-BD43-5E1AAB39613FQ30486707-B2613262-A10F-4667-AE59-38D14DE0810AQ30547823-58571914-0A41-45A3-8717-71E708607B0CQ33664729-FDE7E081-A172-447A-B550-9B6DBB2E24B9Q33712156-3F85FF98-CA73-422D-BA28-1EA7FE5D2C4CQ33714587-F97AFF9D-A096-4FA6-9387-E435848C0B7AQ33751118-2AADA63C-DA4E-4963-BC15-3C2BD2CC51C9Q33791840-9212587A-30BA-4CC5-A48B-B6E0742001D2Q33811998-47566E78-00DF-43CA-A6BB-EC3B17590D27Q33952044-79C341C7-5AB3-46EB-9D5A-16CCF83128D1Q34062823-A15062B6-747B-49F5-BEFB-91EEF4383063Q34064728-CEA4CD5A-E1F5-40A0-919B-5D8502EE45CAQ34084682-037B2D4E-EE63-45AB-BD28-1E777C386295Q34098204-57952986-F4B3-4282-B550-E30A3E8B3C36Q34115272-074FD6CE-6051-4132-BF28-E91F34C958B2Q34141083-24F32E60-AE4C-4679-9456-F75CC38AC2A4Q34190754-B81C7049-608F-4209-B9A9-105954D45CBCQ34201476-6961013F-B7DE-4A18-A92B-EE56A766F695Q34202076-635CBFB2-7A2D-494A-BAEC-F3B93208DA26Q34299290-76CE7B09-5F0D-4031-BCAF-95A007A9620C
P2860
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cannabinoids go nuclear: evide ...... liferator-activated receptors.
@ast
Cannabinoids go nuclear: evide ...... liferator-activated receptors.
@en
type
label
Cannabinoids go nuclear: evide ...... liferator-activated receptors.
@ast
Cannabinoids go nuclear: evide ...... liferator-activated receptors.
@en
prefLabel
Cannabinoids go nuclear: evide ...... liferator-activated receptors.
@ast
Cannabinoids go nuclear: evide ...... liferator-activated receptors.
@en
P2860
P356
P1476
Cannabinoids go nuclear: evide ...... oliferator-activated receptors
@en
P2093
S E O'Sullivan
P2860
P304
P356
10.1038/SJ.BJP.0707423
P407
P577
2007-08-20T00:00:00Z